Manufacturing Technology Transfer: What a Class III Site Move Involves

← Back to All Insights

Technology transfer, moving manufacturing from a pilot site to a commercial site, from one contract manufacturer to another, or into an acquirer's facility, is one of the higher-risk operational events in a medical device company's life. For Class III devices, regulatory requirements add to the operational complexity, and the time, cost and validation work of a serious transfer are easy to underestimate.

Plans that look short on paper tend to stretch in practice, because the transfer is where a company finds out whether its process documentation, supplier qualifications and equipment specifications are what it thought.

What a Real Tech Transfer Includes

A transfer that will hold up to regulators typically includes equipment qualification at the new site (installation, operational and performance qualification, often called IQ/OQ/PQ); validation of processes whose output cannot be fully verified; requalification of any changed suppliers; updated design and production documentation; change control through the whole transfer under the quality system; and monitoring of process capability after the move until performance matches the source site. The Global Harmonization Task Force's process validation guidance for medical devices (GHTF/SG3/N99-10:2004), now hosted by the International Medical Device Regulators Forum, describes this qualification approach.

The Class III Burden

For a device approved through a PMA, FDA's regulations require a PMA supplement, reviewed and approved before the change, for the use of a different facility or establishment to manufacture, process or package the device (21 CFR 814.39(a)). FDA lists this as a PMA manufacturing site change supplement, with a 180-day review period. Changes to manufacturing procedures or methods that affect safety or effectiveness can often go through a 30-day notice instead, though FDA can require a 135-day supplement if the notice is not adequate (21 CFR 814.39(f)). A transfer plan that leaves out these timelines is likely to miss its commercial dates.

Equipment Qualification Realities

Qualification documentation from the original site rarely covers the new site on its own. Differences in utilities, environmental controls, operator training and raw material lots can all require additional qualification and validation work, and transfers stall when the source-site packages do not carry over cleanly.

Process Capability Demonstration

Showing that the new site performs at least as well as the source site takes production runs under statistical control. FDA regulations do not set a single capability index, but many manufacturers use a process capability index (Cpk) of 1.33 or higher as an internal target for critical parameters. Generating enough data takes time, and that runtime belongs in the schedule.

Supplier Qualification

Tech transfers often involve supplier changes, either by choice (consolidating to an acquirer's preferred suppliers) or by necessity (the original supplier cannot serve the new site). Each supplier change requires qualification, possibly design control changes, and an assessment of its impact on process validation. The accumulated supplier work can be the rate-limiting step.

Common Tech Transfer Failure Patterns

Common failure patterns include: (1) the receiving site lacks the manufacturing engineering depth for the transfer's scope; (2) source-site tribal knowledge is poorly documented and leaves before the transfer is complete; (3) equipment specifications were written for the source site and do not generalize; (4) validation packages depend, undocumented, on specific operators or raw material lots; and (5) the change control burden is underestimated, leading either to rushed changes or to delays.

Diligence Implications for Acquirers

Tech transfer is one of the more predictable post-close integration costs. Acquirers should examine the target's manufacturing operations directly: How well documented is the process? How operator-dependent? How well qualified are the suppliers? How robust is change control? And for PMA devices, which supplements would a move require? The answers shape the integration plan and its budget; see our manufacturing due diligence questions.

Tech transfer is not an operational checklist. It is a coordination problem that needs manufacturing engineering depth, regulatory affairs expertise, quality system maturity and operational discipline, and diligence can size that burden before signing rather than after.